Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Gm1 Gangliosidosis Type 1. Data from NIH RePORTER, last 36 months.
Gm1 Gangliosidosis Type 1 has emerging NIH research funding with 1 grant totaling $650K.
1 new grant started in the last 12 months.
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Gm1 Gangliosidosis Type 1. Strongest funded area: Gene Therapy / Cell Therapy. Largest gap: Basic Science.
1 clinical trial registered but no NIH-funded clinical or translational research grants found for GM1 gangliosidosis type 1. Trials may be industry-sponsored or funded through non-NIH sources.
9 publications in Basic Science / Preclinical but no NIH-funded grants found in Basic Science for GM1 gangliosidosis type 1. Existing research activity suggests this may be a viable area for grant applications.
6 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for GM1 gangliosidosis type 1. Existing research activity suggests this may be a viable area for grant applications.